Skip to content

EV / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
3.3×-0.1×
Myriad Genetics logo
Myriad GeneticsMYGN
0.6×-0.4×
Labcorp Holdings logo
Labcorp HoldingsLH
+0.1×
Quest Diagnostics logo
Quest DiagnosticsDGX
2.4×0.0×
NeoGenomics logo
NeoGenomicsNEO
1.2×-0.2×
Natera, Inc. logo
Natera, Inc.NTRA
11×+1.0×

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s EV / sales?
Fulgent Genetics, Inc. (FLGT) reported EV / sales of 1.5× in Q1 2026.
How has Fulgent Genetics, Inc.'s EV / sales changed year-over-year?
Fulgent Genetics, Inc.'s EV / sales decreased by 4.5% year-over-year, from 1.6× to 1.5×.
What is the long-term trend for Fulgent Genetics, Inc.'s EV / sales?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s EV / sales has grown at a -7.3% compound annual growth rate (CAGR), from 3.5× to 2.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.